Information about warrants of series TO 1

In April 2021, Polymer Factory carried out an issue of units (shares and attached free of charge warrants) prior to listing on the Spotlight Stock Market. The issue of units was subscribed to approximately 687 percent and all shares and warrants were subsequently issued.

A total of 586,066 warrants of series TO 1 were issued. During the exercise period, from 24 February 2022 to 17 March 2022, the warrant holder has the opportunity to subscribe for one (1) new share at a price of SEK 9.10 per share. Through the warrant exercise, the Company can receive a total of maximum approximately SEK 5.2 million before issue costs of approximately SEK 0.5 million.

The proceeds from warrant exercise are intended to be used to accelerate sales and match the need of customers by recruiting key personnel with expertise in sales, as well as increasing marketing activities and expanding the Company’s offering to the market.

Important dates

February 24, 2022 – Exercise period begins

March 15, 2022 – Last day of trading in the warrants

March 17, 2022 – Exercise period ends

March 22, 2022 – Planed date for publication of warrant exercise outcome

April 4, 2022 – Planed date for conversion of interim shares to ordinary shares

Warrants of series TO 1 in summary

Exercise period: 24 February – 17 March 2022.

Subscription prince: Each warrant of series TO 1 gives the holder the right to subscribe for one (1) new share in Polymer Factory at a price of SEK 9.10.

Issue volume: There are 568,066 outstanding warrants of series TO 1. Upon full exercise of warrants Polymer Factory will receive approx. SEK 5.2 million before deduction of transaction related costs.

Last day of trading in warrants: 15 March 2022.

Number of outstanding shares in Polymer Factory: 6,859,198 shares.

Valuation in the current offer: Approx. SEK 62.4 million.

Teaser and subscription form

Teaser and subscription form are made available as of today on Polymer Factory’s (www.polymerfactory.com), Sedermera Corporate Finance’s (www.sedermera.se) and Nordic Issuing’s (www.nordic-issuing.se) websites. Terms and conditions and more information about the exercise of the warrants are also available on the above websites.

For more information about Polymer Factory, please contact:
Elin Mignérus, CEO
Phone: +46 (0) 79 300 27 76
E-mail: elin.mignerus@polymerfactory.com

For more information on warrants of series TO 1, please contact:
Sedermera Corporate Finance
Phone: +46 (0) 40 615 14 10
Email: info@sedermera.se
www.sedermera.se

Polymer Factory (publ) is a leading global provider and producer of dendritic materials, with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g. a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com.